Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Working Knowledge
Business Research for Business Leaders
  • Browse All Articles
  • Popular Articles
  • Cold Call Podcasts
  • About Us
  • Leadership
  • Marketing
  • Finance
  • Management
  • Entrepreneurship
  • All Topics...
  • Topics
    • COVID-19
    • Entrepreneurship
    • Finance
    • Gender
    • Globalization
    • Leadership
    • Management
    • Negotiation
    • Social Enterprise
    • Strategy
  • Sections
    • Book
    • Cold Call Podcast
    • HBS Case
    • In Practice
    • Lessons from the Classroom
    • Op-Ed
    • Research & Ideas
    • Research Event
    • Sharpening Your Skills
    • What Do You Think?
    • Working Paper Summaries
  • Browse All
    • COVID-19 Business Impact Center
      COVID-19 Business Impact Center
      Cold Call
      A podcast featuring faculty discussing cases they've written and the lessons they impart.
      Subscribe on iTunes
      • 20 Apr 2021
      • Cold Call Podcast

      What Went Wrong with the Boeing 737 Max?

      How did the evolution of Boeing’s organization and management lead up to two tragic plane crashes—the crash of Lion Air flight 610 on October 29, 2018, in Indonesia, and the crash of Ethiopian Airlines flight 302 on March 9, 2019, in Ethiopia—in which a total of 346 people died? What role did cost cutting, FAA pressure, and CEO succession play in laying the foundation for this tragedy? Professor Bill George discusses the long roots that ultimately led to two tragic Boeing 737 Max crashes, and examines the response of Boeing executives to the crisis in his case, “What Went Wrong with Boeing's 737 Max?”  Open for comment; 0 Comment(s) posted.

      Read the Transcript

      Filter Results: (8) Arrow Down
      Filter Results: (8) Arrow Down Arrow Up
      • Popular
      • Browse All Articles
      • About Us
      • Newsletter Sign-Up
      • RSS
      • Popular
      • Browse All Articles
      • About Us
      • Newsletter Sign-Up
      • RSS

      Health Testing and TrialsRemove Health Testing and Trials →

      Page 1 of 8 Results
      • 03 Jun 2020
      • Research & Ideas

      Who Guarantees Your Workplace Is Safe for Return?

      by John Macomber and Joseph Allen

      Building health is today a top priority for owners and tenants, but how do we know our offices are safe to re-enter? John Macomber and Joseph Allen offer best practices. Open for comment; Comment(s) posted.

      • 12 Aug 2019
      • Working Paper Summaries

      Case Histories of Significant Medical Advances

      by Amar Bhidé, Srikant M. Datar, and Katherine Stebbins

      Nine working papers by Srikant M. Datar and colleagues explore technologies pioneered during the late 20th century that US internists say have greatly improved patient care.

      • 16 Apr 2019
      • Working Paper Summaries

      Can Biometric Tracking Improve Healthcare Provision and Data Quality? Experimental Evidence from Tuberculosis Control in India

      by Thomas Bossuroy, Clara Delavallade, and Vincent Pons

      This paper shows the benefits of biometric technology for strengthening service delivery and improving reliability of government data. The technology improved productivity of health workers operating tuberculosis treatment centers and decreased misreporting.

      • 31 Jul 2018
      • Working Paper Summaries

      How Does Product Liability Risk Affect Innovation? Evidence from Medical Implants

      by Alberto Galasso and Hong Luo

      This analysis examines how a surge in liability risk faced by upstream suppliers of general purpose technologies (polymers) affected downstream innovation in implant technologies. Implant patenting dropped by 36 percent relative to non-implant technologies.

      • 12 Jun 2018
      • Research & Ideas

      In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?

      by Rachel Layne

      Pharmaceutical companies are criticized for not producing more breakthrough drugs. But new research by Joshua Krieger and colleagues shows that, given a financial windfall, drug giants turn on the innovation. Open for comment; Comment(s) posted.

      • 08 Mar 2018
      • Cold Call Podcast

      Could a New Business Model Make Clinical Drug Trials More Accessible to Patients?

      Ariel Stern discusses her recent case study about creating a new type of clinical trial designed to deliver life-enhancing drugs to patients more quickly. Open for comment; Comment(s) posted.

      • 11 Nov 2015
      • Working Paper Summaries

      Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules

      by Danielle Li

      By tracing the often-circuitous path from National Institutes of Health (NIH) funding to patented innovations, this research examines the effects of public science on private sector innovation in the life sciences.

      • 05 Nov 2009
      • Research & Ideas

      A Market for Human Cadavers in All but Name?

      by Michel Anteby

      A shortage of cadavers has hampered medical education and training, a market that entrepreneurs are stepping forward to address. HBS professor Michel Anteby argues that scholars must learn more about the market dynamics of this uncomfortable subject in order to inform political debate. Closed for comment; 0 Comment(s) posted.

      • 1
      ǁ
      Campus Map
      Harvard Business School Working Knowledge
      Baker Library | Bloomberg Center
      Soldiers Field
      Boston, MA 02163
      Email: Editor-in-Chief
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College